Latest period
578M
YoY change
-2.3%
5Y CAGR
-1.5%
Peak year (FY2006)
767M
Latest annual
586M
Shares Outstanding history chart for Edwards Lifesciences (EW) from 2016 to 2025
Latest: 586M
Shares Outstanding growth chart for Edwards Lifesciences (EW) from 2016 to 2025
Latest: -2.3%
Shares Outstanding history table for Edwards Lifesciences (EW) from 1999 to 2025
| FY2025 | 586M | -2.3% | -13.5M | ||
| FY2024 | 599M | -1.7% | -10.1M | ||
| FY2023 | 609M | -2.4% | -14.8M | ||
| FY2022 | 624M | -1.1% | -7M | ||
| FY2021 | 631M | -0.1% | -700K | ||
| FY2020 | 632M | -0.7% | -4.7M | ||
| FY2019 | 637M | -0.7% | -4.2M | ||
| FY2018 | 641M | -1.1% | -6.9M | ||
| FY2017 | 648M | -0.9% | -5.7M | ||
| FY2016 | 653M | -1.1% | -7.5M | ||
| FY2015 | 661M | +1.5% | +9.9M | ||
| FY2014 | 651M | -4.7% | -31.8M | ||
| FY2013 | 683M | -3.8% | -27M | ||
| FY2012 | 710M | -0.9% | -6.6M | ||
| FY2011 | 716M | +0.2% | +1.2M | ||
| FY2010 | 715M | +1.5% | +10.8M | ||
| FY2009 | 704M | -1.5% | -10.8M | ||
| FY2008 | 715M | -4.9% | -37.2M | ||
| FY2007 | 752M | -1.9% | -14.4M | ||
| FY2006 | 767M | +2.6% | +19.2M | ||
| FY2005 | 748M | +0.5% | +3.6M | ||
| FY2004 | 744M | +1.5% | +10.8M | ||
| FY2003 | 733M | -0.3% | -2.4M | ||
| FY2002 | 736M | +4.1% | +28.8M | ||
| FY2001 | 707M | +1.4% | +9.73M | ||
| FY2000 | 697M | 0.0% | 0 | ||
| FY1999 | 697M | — | — |
- FY2025586M-2.3%
- FY2024599M-1.7%
- FY2023609M-2.4%
- FY2022624M-1.1%
- FY2021631M-0.1%
- FY2020632M-0.7%
- FY2019637M-0.7%
- FY2018641M-1.1%
- FY2017648M-0.9%
- FY2016653M-1.1%
- FY2015661M+1.5%
- FY2014651M-4.7%
- FY2013683M-3.8%
- FY2012710M-0.9%
- FY2011716M+0.2%
- FY2010715M+1.5%
- FY2009704M-1.5%
- FY2008715M-4.9%
- FY2007752M-1.9%
- FY2006767M+2.6%
- FY2005748M+0.5%
- FY2004744M+1.5%
- FY2003733M-0.3%
- FY2002736M+4.1%
- FY2001707M+1.4%
- FY2000697M0.0%
- FY1999697M—
Shares Outstanding values are taken from Edwards Lifesciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported diluted shares outstanding is 578M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Edwards Lifesciences (EW) diluted shares outstanding is 586M – edged down 2.3% year-over-year.
Edwards Lifesciences diluted shares outstanding has contracted on net over the period, with a -1.5% compound annual growth rate over 2020–2025 (5 years).
Edwards Lifesciences diluted shares outstanding peaked at 767M in 2006; the latest annual figure is 586M in 2025 (23.6% below peak).
767M stands as the all-time-high annual diluted shares outstanding, posted in 2006, against a low of 586M during 2025.
Edwards Lifesciences Shares Outstanding by Year
Edwards Lifesciences Shares Outstanding 2025: 586M
In 2025, Edwards Lifesciences reported diluted shares outstanding of 586M, edged down 2.3% below 2024. This figure represents the lowest annual value in the available history.
Edwards Lifesciences Shares Outstanding 2024: 599M
Edwards Lifesciences diluted shares outstanding in 2024 was 599M, edged down 1.7% below 2023.
Edwards Lifesciences Shares Outstanding 2023: 609M
2023's diluted shares outstanding for Edwards Lifesciences came in at 609M, edged down 2.4% below 2022.
Edwards Lifesciences Shares Outstanding 2022: 624M
Edwards Lifesciences posted diluted shares outstanding of 624M in 2022, edged down 1.1% below 2021.
Edwards Lifesciences Shares Outstanding 2021: 631M
Edwards Lifesciences diluted shares outstanding in 2021 was 631M.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Shares Outstanding
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest diluted shares outstanding
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.